ORIGINAL PAPER
The state of refraction in prematurely born children with retinopathy depending on treatment methods used (diode laser and anti-VEGF) and selected demographic characteristics – observations
1
Second Department of Ophthalmology, Pomeranian Medical University, Szczecin, Poland
2
Scientific Students Association of Ophtalmology, Second Department of Ophthalmology, Pomeranian Medical University, Szczecin, Poland
3
Independent Laboratory of Biostatistics, Pomeranian Medical University, Szczecin, Poland
Submission date: 2022-10-29
Final revision date: 2023-01-03
Acceptance date: 2023-01-04
Publication date: 2023-06-16
Corresponding author
Monika Modrzejewska
Second Department of Ophthalmology, Pomeranian Medical University, Szczecin, Poland
Second Department of Ophthalmology, Pomeranian Medical University, Szczecin, Poland
Pediatr Pol 2023;98(2):108-115
KEYWORDS
TOPICS
ABSTRACT
Introduction::
The authors present the prevalence of refractive errors in premature infants, demonstrating the relationship between refractive development and selected demographic characteristics and the forms of treatment used: diode laser, anti-vascular endothelial growth factor (anti-VEGF) and combination therapy.
Material and methods::
The study included 56 healthy children without retinopathy of prematurity (ROP) and 63 children with ROP. Ophthalmologic evaluation and diagnosis were performed according to the International Classification of Retinopathy of Prematurity assessed in Ret-Cam 3. Treatment of ROP was carried out according to the guidelines of the Polish Ophthalmological Society using a diode laser (IRIDEX IQ 810) and an anti-VEGF intravitreal preparation (ranibizumab, Lucentis) at a reduced dose of 0.18 mg. Refractive measurements were taken at 7 months of age using a handheld computerized autorefractometer (Retinomax) after 1% tropicamide cycloplegia.
Results::
A statistically significantly higher prevalence of high myopia (p = 0.019) and low astigmatism (p < 0.001) was observed in the eyes of premature infants with ROP and moderate hyperopia in the group without ROP (p = 0.031) regardless of the treatment used [mean +1.33 spherical diopters (Dsfr.); SD ±3.09 for eyes with ROP vs. mean +2.42 Dsfr.; SD ±2.11 for eyes without ROP]. Birth weight (p = 0.01) and gestational age (p = 0.048) correlated with changes in spherical refraction in children with ROP. There were statistically significant differences in high myopia (p = 0.041), low myopia (p = 0.010) and low hyperopia (p = 0.014) in the group of premature infants treated for ROP depending on the form of therapy.
Conclusions::
There were statistically significant differences in high myopia (p = 0.041), low myopia (p = 0.010) and low hyperopia (p = 0.014) in the groups of premature infants with ROP and high myopia (p = 0.019) and low astigmatism (p < 0.001) in the groups treated with monotherapy or combined therapy. Birth weight (p = 0.01) and gestational age (p = 0.048) had a significant effect on refractive development in eyes with ROP.
The authors present the prevalence of refractive errors in premature infants, demonstrating the relationship between refractive development and selected demographic characteristics and the forms of treatment used: diode laser, anti-vascular endothelial growth factor (anti-VEGF) and combination therapy.
Material and methods::
The study included 56 healthy children without retinopathy of prematurity (ROP) and 63 children with ROP. Ophthalmologic evaluation and diagnosis were performed according to the International Classification of Retinopathy of Prematurity assessed in Ret-Cam 3. Treatment of ROP was carried out according to the guidelines of the Polish Ophthalmological Society using a diode laser (IRIDEX IQ 810) and an anti-VEGF intravitreal preparation (ranibizumab, Lucentis) at a reduced dose of 0.18 mg. Refractive measurements were taken at 7 months of age using a handheld computerized autorefractometer (Retinomax) after 1% tropicamide cycloplegia.
Results::
A statistically significantly higher prevalence of high myopia (p = 0.019) and low astigmatism (p < 0.001) was observed in the eyes of premature infants with ROP and moderate hyperopia in the group without ROP (p = 0.031) regardless of the treatment used [mean +1.33 spherical diopters (Dsfr.); SD ±3.09 for eyes with ROP vs. mean +2.42 Dsfr.; SD ±2.11 for eyes without ROP]. Birth weight (p = 0.01) and gestational age (p = 0.048) correlated with changes in spherical refraction in children with ROP. There were statistically significant differences in high myopia (p = 0.041), low myopia (p = 0.010) and low hyperopia (p = 0.014) in the group of premature infants treated for ROP depending on the form of therapy.
Conclusions::
There were statistically significant differences in high myopia (p = 0.041), low myopia (p = 0.010) and low hyperopia (p = 0.014) in the groups of premature infants with ROP and high myopia (p = 0.019) and low astigmatism (p < 0.001) in the groups treated with monotherapy or combined therapy. Birth weight (p = 0.01) and gestational age (p = 0.048) had a significant effect on refractive development in eyes with ROP.
REFERENCES (35)
1.
Kuo A, Sinatra RB, Donahue SP. Distribution of refractive error in healthy infants. J AAPOS 2003; 7: 174-177.
2.
Snir M, Friling R, Weinberger D, et al. Refraction and keratometry in 40 week old premature (corrected age) and term infants. Br J Ophthalmol 2004; 88: 900-904.
3.
Semeraro F, Forbice E, Nascimbeni G, et al. Ocular refraction at birth and its development during the first year of life in a large cohort of babies in a single center in Northern Italy. Front Pediatr 2020; 7: 539.
4.
Groot ALW, Lissenberg-Witte BI, van Rijn LJ, Hartong DT. Meta-analysis of ocular axial length in newborns and infants up to 3 years of age. Surv Ophthalmol. 2022; 67: 342-352.
5.
Ton Y, Wysenbeek YS, Spierer A. Refractive error in premature infants. J AAPOS 2004; 8: 534-538.
6.
Munro RJ, Fulton AB, Chui TY, et al. Eye growth in term- and preterm-born eyes modeled from magnetic resonance images. Invest Ophthalmol Vis Sci 2015; 56: 3121-3131.
7.
Bhatti S, Paysse EA, Weikert MP, et al. Evaluation of structural contributors in myopic eyes of preterm and full-term children. Graefes Arch Clin Exp Ophthalmol 2016; 254: 957-962.
8.
Liang J. Systematic review and meta-analysis of the negative outcomes of retinopathy of prematurity treated with laser photocoagulation. Eur J Ophthalmol 2019; 29: 223-228.
9.
Kong Q, Ming WK, Mi XS. Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis. BMJ Open 2021; 11: e042384.
10.
Chiang MF, Quinn GE, Fielder AR, et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology 2021; 128: e51-e68.
11.
Gotz-Więckowska A, Bakunowicz-Łazarczyk A, Hautz W, et al. Polish Ophthalmological Society revised guidelines for the management of retinopathy of prematurity. Acta Ophthalmol Pol 2020; 122: 14-16.
12.
EMA. Lucentis – European Medicines Agency. European Medicines Agency. Available from: https://www.ema.europa.eu/en/m... (accessed: 24.03.2022).
13.
Galvis V, Tello A, Camacho PA, et al. Definition of refractive errors for research studies: spherical equivalent could not be enough. J Optom 2021; 14: 224-225.
14.
Refractive errors & refractive surgery PPP – 2017. American Academy of Ophthalmology. Available from: https://www.aao.org/preferred-... (lastly accessed: 09.09.2017).
15.
Zhu X, Zhao R, Wang Y, et al. Refractive state and optical compositions of preterm children with and without retinopathy of prematurity in the first 6 years of life. Medicine (Baltimore) 2017; 96: e8565.
16.
Fu Z, Yang H, Yin X, et al. Characteristics and associated factors of early refractive parameters in premature infants. Zhonghua Yan Ke Za Zhi 2021; 57: 353-357.
17.
Uprety S, Morjaria P, Shrestha JB, et al. Refractive status in nepalese pre-term and full-term infants early in life. Optom Vis Sci 2017; 94: 957-964.
18.
Modrzejewska M, Grzesiak W, Karczewicz D, et al. Refractive status and ocular axial length in preterm infants without retinopathy of prematurity with regard to birth weight and gestational age. J Perinat Med 2010; 38: 327-331.
19.
Mao J, Lao J, Liu C, et al. Factors that influence refractive changes in the first year of myopia development in premature infants. J Ophthalmol 2019; 2019: 7683749.
20.
Sathar A, Abbas S, Nujum ZT, Benson JL, Sreedevi GP, Saraswathyamma SK. Visual outcome of preterm infants screened in a tertiary care hospital. Middle East Afr J Ophthalmol 2019; 26: 158-162.
21.
Tiryaki Demir S, Keles Yesiltas S, Karapapak M, et al. Evaluation of the effect of different treatment management on refractive outcomes in severe retinopathy of prematurity. Sisli Etfal Hastan Tip Bul 2021; 55: 545-550.
22.
Laveti V, Balakrishnan D, Rani PK, et al. Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP Study (ITCROPS) database report number 9. Int Ophthalmol 2020; 40: 3539-3545.
23.
Mori Y, Arima M, Ueda E, et al. Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity. Eye (Lond) 2021; 35: 2820-2825.
24.
Anilkumar SE, Anandi V, Shah PK, et al. Refractive, sensory, and biometric outcome among retinopathy of prematurity children with a history of laser therapy: a retrospective review from a tertiary care center in South India. Indian J Ophthalmol 2019; 67: 871-876.
25.
Kaur S, Dogra M, Sukhija J, et al. Preterm refraction and ocular biometry in children with and without retinopathy of prematurity in the first year of life. J AAPOS 2021; 25: 271.e1-271.e6.
26.
Katoch D, Sanghi G, Dogra MR, et al. Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes. Indian J Ophthalmol 2011; 59: 423-426.
27.
Inoue T, Asaoka R, Hashimoto Y, et al. Does the number of laser applications for ROP treatment influence the degree of myopia? Graefes Arch Clin Exp Ophthalmol 2021; 259: 317-322.
28.
Lajoie JE, Pacheco RR, Shah V, et al. A comparison of primary laser versus laser after anti-vascular endothelial growth factor for type 1 retinopathy of prematurity. J AAPOS 2022; 26: 191.e1-191.e4.
29.
Geloneck MM, Chuang AZ, Clark WL, et al. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol 2014; 132: 1327-1333.
30.
Stahl A, Krohne TU, Eter N, et al. Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial. JAMA Pediatr 2018; 172: 278-286.
31.
Ittarat M. Comparison of outcomes between combined sparing laser photocoagulation and intravitreal bevacizumab treatment versus conventional laser photocoagulation in aggressive posterior retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2021; 58: 292-297.
32.
Kimyon S, Mete A. Comparison of bevacizumab and ranibizumab in the treatment of type 1 retinopathy of prematurity affecting zone 1. Ophthalmologica 2018; 240: 99-105.
33.
Gunay M, Sukgen EA, Celik G, Kocluk Y. Comparison of bevacizumab, ranibizumab, and laser photocoagulation in the treatment of retinopathy of prematurity in Turkey. Current eye research 2017; 42: 462-469.
34.
Chen SN, Lian I, Hwang YC, et al. Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between ranibizumab and bevacizumab. Retina 2015; 35: 667-674.
35.
Chen YC, Chen SN, Yang BC, Lee KH, Chuang CC, Cheng CY. Refractive and biometric outcomes in patients with retinopathy of prematurity treated with intravitreal injection of ranibizumab as compared with bevacizumab: a clinical study of correction at three years of age. J Ophthalmol 2018; 2018: 4565216.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
